The DOI matches its Crossref record; 413 of the 413 references it cites were found in a registry or an index.
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Open accessAbstract
Positron emission tomography (PET) uses radioactive tracers and enables the functional imaging of several metabolic processes, blood flow measurements, regional chemical composition, and/or chemical absorption. Depending on the targeted processes within the living organism, different tracers are used for various medical conditions, such as cancer, particular brain pathologies, cardiac events, and bone lesions, where the most commonly used tracers are radiolabeled with 18F (e.g., [18F]-FDG and NA [18F]). Oxygen-15 isotope is mostly involved in blood flow measurements, whereas a wide array of 11C-based compounds have also been developed for neuronal disorders according to the affected neuroreceptors, prostate cancer, and lung carcinomas. In contrast, the single-photon emission computed tomography (SPECT) technique uses gamma-emitting radioisotopes and can be used to diagnose strokes, seizures, bone illnesses, and infections by gauging the blood flow and radio distribution within tissues and organs. The radioisotopes typically used in SPECT imaging are iodine-123, technetium-99m, xenon-133, thallium-201, and indium-111. This systematic review article aims to clarify and disseminate the available scientific literature focused on PET/SPECT radiotracers and to provide an overview of the conducted research within the past decade, with an additional focus on the novel radiopharmaceuticals developed for medical imaging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog
Mettler, F. A., Huda, W., Yoshizumi, T. T., & Mahesh, M. (2008) · Radiology · doi:10.1148/radiol.2481071451 · Cited by 2,008
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., O’Neil, J. P., Janabi, M., Lazaris, A., Cantwell, A., et al. (2016) · Brain · doi:10.1093/brain/aww027 · Cited by 1,185
Tau positron emission tomographic imaging in aging and early Alzheimer disease
Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., Mormino, E., Chhatwal, J., Amariglio, R., Papp, K., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24546 · Cited by 986
Owen, D. R., Yeo, A. J., Gunn, R. N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D. J., Bennacef, I., Parker, C. A., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.147 · Cited by 779
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Bejanin, A., Schonhaut, D. R., La Joie, R., Kramer, J. H., Baker, S. L., Sosa, N., Ayakta, N., Cantwell, A., Janabi, M., Lauriola, M., et al. (2017) · Brain · doi:10.1093/brain/awx243 · Cited by 778
Bensch, F., van der Veen, E. L., Lub-de Hooge, M. N., Jorritsma-Smit, A., Boellaard, R., Kok, I. C., Oosting, S. F., Schröder, C. P., Hiltermann, T. J. N., van der Wekken, A. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0255-8 · Cited by 732
Role of Bruton’s tyrosine kinase in B cells and malignancies
Pal Singh, S., Dammeijer, F., & Hendriks, R. W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0779-z · Cited by 726
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
Chien, D. T., Szardenings, A. K., Bahri, S., Walsh, J. C., Mu, F., Xia, C., Shankle, W. R., Lerner, A. J., Su, M.-Y., Elizarov, A., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130098 · Cited by 675
Rabinovici, G. D., Gatsonis, C., Apgar, C., Chaudhary, K., Gareen, I., Hanna, L., Hendrix, J., Hillner, B. E., Olson, C., Lesman-Segev, O. H., et al. (2019) · JAMA · doi:10.1001/jama.2019.2000 · Cited by 674
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807
Chien, D. T., Bahri, S., Szardenings, A. K., Walsh, J. C., Mu, F., Su, M.-Y., Shankle, W. R., Elizarov, A., & Kolb, H. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122059 · Cited by 651
Tau PET imaging in neurodegenerative tauopathies—still a challenge
Leuzy, A., Chiotis, K., Lemoine, L., Gillberg, P.-G., Almkvist, O., Rodriguez-Vieitez, E., & Nordberg, A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0342-8 · Cited by 628
Current use of PSMA–PET in prostate cancer management
Maurer, T., Eiber, M., Schwaiger, M., & Gschwend, J. E. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.26 · Cited by 611
[ 18 F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Xia, C., Arteaga, J., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., Mocharla, V. P., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.008 · Cited by 605
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Sabri, O., Sabbagh, M. N., Seibyl, J., Barthel, H., Akatsu, H., Ouchi, Y., Senda, K., Murayama, S., Ishii, K., Takao, M., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.004 · Cited by 602
Imaging synaptic density in the living human brain
Finnema, S. J., Nabulsi, N. B., Eid, T., Detyniecki, K., Lin, S.-F., Chen, M.-K., Dhaher, R., Matuskey, D., Baum, E., Holden, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6667 · Cited by 575
Waterhouse, R. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.014 · Cited by 567
Predicting plasma protein binding of drugs: a new approach
Kratochwil, N. A., Huber, W., Müller, F., Kansy, M., & Gerber, P. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01074-2 · Cited by 553
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30314-8 · Cited by 526
DeFuria, J., Belkina, A. C., Jagannathan-Bogdan, M., Snyder-Cappione, J., Carr, J. D., Nersesova, Y. R., Markham, D., Strissel, K. J., Watkins, A. A., Zhu, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215840110 · Cited by 521
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
Niemeijer, A. N., Leung, D., Huisman, M. C., Bahce, I., Hoekstra, O. S., van Dongen, G. A. M. S., Boellaard, R., Du, S., Hayes, W., Smith, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07131-y · Cited by 484
Danad, I., Raijmakers, P. G., Driessen, R. S., Leipsic, J., Raju, R., Naoum, C., Knuuti, J., Mäki, M., Underwood, R. S., Min, J. K., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2471 · Cited by 475
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Lowe, V. J., Curran, G., Fang, P., Liesinger, A. M., Josephs, K. A., Parisi, J. E., Kantarci, K., Boeve, B. F., Pandey, M. K., Bruinsma, T., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0315-6 · Cited by 474
Detection of Atherosclerotic Inflammation by 68 Ga-DOTATATE PET Compared to [ 18 F]FDG PET Imaging
Tarkin, J. M., Joshi, F. R., Evans, N. R., Chowdhury, M. M., Figg, N. L., Shah, A. V., Starks, L. T., Martin-Garrido, A., Manavaki, R., Yu, E., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.060 · Cited by 445
A review on the clinical uses of SPECT/CT
Mariani, G., Bruselli, L., Kuwert, T., Kim, E. E., Flotats, A., Israel, O., Dondi, M., & Watanabe, N. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1390-8 · Cited by 438
Tagawa, S. T., Milowsky, M. I., Morris, M., Vallabhajosula, S., Christos, P., Akhtar, N. H., Osborne, J., Goldsmith, S. J., Larson, S., Taskar, N. P., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0231 · Cited by 427
Zechmann, C. M., Afshar-Oromieh, A., Armor, T., Stubbs, J. B., Mier, W., Hadaschik, B., Joyal, J., Kopka, K., Debus, J., Babich, J. W., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2713-y · Cited by 358
Gebhart, G., Lamberts, L. E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv577 · Cited by 355
Mc Ardle, B. A., Dowsley, T. F., deKemp, R. A., Wells, G. A., & Beanlands, R. S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.038 · Cited by 348
Dweck, M. R., Jones, C., Joshi, N. V., Fletcher, A. M., Richardson, H., White, A., Marsden, M., Pessotto, R., Clark, J. C., Wallace, W. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.051052 · Cited by 337
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
Schmitz, T. W., Nathan Spreng, R., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13249 · Cited by 335
Curtis, C., Gamez, J. E., Singh, U., Sadowsky, C. H., Villena, T., Sabbagh, M. N., Beach, T. G., Duara, R., Fleisher, A. S., Frey, K. A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4144 · Cited by 332
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Harada, R., Okamura, N., Furumoto, S., Furukawa, K., Ishiki, A., Tomita, N., Tago, T., Hiraoka, K., Watanuki, S., Shidahara, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.164848 · Cited by 330
Danad, I., Uusitalo, V., Kero, T., Saraste, A., Raijmakers, P. G., Lammertsma, A. A., Heymans, M. W., Kajander, S. A., Pietilä, M., James, S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.069 · Cited by 330
Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction
Thackeray, J. T., Hupe, H. C., Wang, Y., Bankstahl, J. P., Berding, G., Ross, T. L., Bauersachs, J., Wollert, K. C., & Bengel, F. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.024 · Cited by 302
Ziadi, M. C., deKemp, R. A., Williams, K., Guo, A., Renaud, J. M., Chow, B. J. W., Klein, R., Ruddy, T. D., Aung, M., Garrard, L., et al. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-011-9506-5 · Cited by 301
Okamura, N., Furumoto, S., Harada, R., Tago, T., Yoshikawa, T., Fodero-Tavoletti, M., Mulligan, R. S., Villemagne, V. L., Akatsu, H., Yamamoto, T., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.117341 · Cited by 290
The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment
Sasaki, T., Hiroki, K., & Yamashita, Y. (2013) · BioMed Research International · doi:10.1155/2013/546318 · Cited by 285
Tau PET imaging: present and future directions
Saint-Aubert, L., Lemoine, L., Chiotis, K., Leuzy, A., Rodriguez-Vieitez, E., & Nordberg, A. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0162-3 · Cited by 282
Werry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
Hostetler, E. D., Walji, A. M., Zeng, Z., Miller, P., Bennacef, I., Salinas, C., Connolly, B., Gantert, L., Haley, H., Holahan, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.171678 · Cited by 273
Tau-based therapies in neurodegeneration: opportunities and challenges
Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
Cencioni, M. T., Mattoscio, M., Magliozzi, R., Bar-Or, A., & Muraro, P. A. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00498-5 · Cited by 271
Tau PET in Alzheimer disease and mild cognitive impairment
Cho, H., Choi, J. Y., Hwang, M. S., Lee, J. H., Kim, Y. J., Lee, H. M., Lyoo, C. H., Ryu, Y. H., & Lee, M. S. (2016) · Neurology · doi:10.1212/wnl.0000000000002892 · Cited by 270
Gaemperli, O., Shalhoub, J., Owen, D. R. J., Lamare, F., Johansson, S., Fouladi, N., Davies, A. H., Rimoldi, O. E., & Camici, P. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr367 · Cited by 267
Imbert, L., Poussier, S., Franken, P. R., Songy, B., Verger, A., Morel, O., Wolf, D., Noel, A., Karcher, G., & Marie, P.-Y. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.107417 · Cited by 267
B Cells in Rheumatoid Arthritis:Pathogenic Mechanisms and Treatment Prospects
Wu, F., Gao, J., Kang, J., Wang, X., Niu, Q., Liu, J., & Zhang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750753 · Cited by 267
Cholinergic Dysfunction in Parkinson’s Disease
Müller, M. L. T. M., & Bohnen, N. I. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0377-9 · Cited by 264
SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0
Minoshima, S., Drzezga, A. E., Barthel, H., Bohnen, N., Djekidel, M., Lewis, D. H., Mathis, C. A., McConathy, J., Nordberg, A., Sabri, O., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.174615 · Cited by 262
Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances
Wen, T., Wang, J., Shi, Y., Qian, H., & Liu, P. (2021) · Leukemia · doi:10.1038/s41375-020-01072-6 · Cited by 262
The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer
Afshar-Oromieh, A., Babich, J. W., Kratochwil, C., Giesel, F. L., Eisenhut, M., Kopka, K., & Haberkorn, U. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170720 · Cited by 257
Pandit-Taskar, N., Postow, M. A., Hellmann, M. D., Harding, J. J., Barker, C. A., O’Donoghue, J. A., Ziolkowska, M., Ruan, S., Lyashchenko, S. K., Tsai, F., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.229781 · Cited by 257
Synthesis of [18F]Arenes via the Copper-Mediated [18F]Fluorination of Boronic Acids
Mossine, A. V., Brooks, A. F., Makaravage, K. J., Miller, J. M., Ichiishi, N., Sanford, M. S., & Scott, P. J. H. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b02875 · Cited by 251
Positron emission tomography and functional characterization of a complete PBR/TSPO knockout
Banati, R. B., Middleton, R. J., Chan, R., Hatty, C. R., Wai-Ying Kam, W., Quin, C., Graeber, M. B., Parmar, A., Zahra, D., Callaghan, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6452 · Cited by 241
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.
Lopci, E., Grassi, I., Chiti, A., Nanni, C., Cicoria, G., Toschi, L., Fonti, C., Lodi, F., Mattioli, S., & Fanti, S. (2014) · PubMed · Cited by 235
Robu, S., Schottelius, M., Eiber, M. J., Maurer, T., Gschwend, J. E., Schwaiger, M., & Wester, H. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178939 · Cited by 235
Prognostic Value of Stress Myocardial Perfusion Positron Emission Tomography
Dorbala, S., Di Carli, M. F., Beanlands, R. S., Merhige, M. E., Williams, B. A., Veledar, E., Chow, B. J. W., Min, J. K., Pencina, M. J., Berman, D. S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.043 · Cited by 232
Weinstein, E. A., Ordonez, A. A., DeMarco, V. P., Murawski, A. M., Pokkali, S., MacDonald, E. M., Klunk, M., Mease, R. C., Pomper, M. G., & Jain, S. K. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009815 · Cited by 232
Hillier, S. M., Maresca, K. P., Lu, G., Merkin, R. D., Marquis, J. C., Zimmerman, C. N., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.116624 · Cited by 230
Zürcher, N. R., Loggia, M. L., Lawson, R., Chonde, D. B., Izquierdo-Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., Cudkowicz, M. E., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.009 · Cited by 226
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
Sehlin, D., Fang, X. T., Cato, L., Antoni, G., Lannfelt, L., & Syvänen, S. (2016) · Nature Communications · doi:10.1038/ncomms10759 · Cited by 225
Kroth, H., Oden, F., Molette, J., Schieferstein, H., Capotosti, F., Mueller, A., Berndt, M., Schmitt-Willich, H., Darmency, V., Gabellieri, E., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04397-2 · Cited by 225
Israel, O., Pellet, O., Biassoni, L., De Palma, D., Estrada-Lobato, E., Gnanasegaran, G., Kuwert, T., la Fougère, C., Mariani, G., Massalha, S., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04404-6 · Cited by 225
Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand
Cselényi, Z., Jönhagen, M. E., Forsberg, A., Halldin, C., Julin, P., Schou, M., Johnström, P., Varnäs, K., Svensson, S., & Farde, L. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.094029 · Cited by 224
Aghourian, M., Legault-Denis, C., Soucy, J.-P., Rosa-Neto, P., Gauthier, S., Kostikov, A., Gravel, P., & Bédard, M.-A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.183 · Cited by 220
Finnema, S. J., Nabulsi, N. B., Mercier, J., Lin, S.-F., Chen, M.-K., Matuskey, D., Gallezot, J.-D., Henry, S., Hannestad, J., Huang, Y., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17724947 · Cited by 218
Narayanaswami, V., Dahl, K., Bernard-Gauthier, V., Josephson, L., Cumming, P., & Vasdev, N. (2018) · Molecular Imaging · doi:10.1177/1536012118792317 · Cited by 213
Hannestad, J., Gallezot, J.-D., Schafbauer, T., Lim, K., Kloczynski, T., Morris, E. D., Carson, R. E., Ding, Y.-S., & Cosgrove, K. P. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.055 · Cited by 212
Berman, D. S., Maddahi, J., Tamarappoo, B. K., Czernin, J., Taillefer, R., Udelson, J. E., Gibson, C. M., Devine, M., Lazewatsky, J., Bhat, G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.022 · Cited by 208
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
Barrett, J. A., Coleman, R. E., Goldsmith, S. J., Vallabhajosula, S., Petry, N. A., Cho, S., Armor, T., Stubbs, J. B., Maresca, K. P., Stabin, M. G., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111203 · Cited by 208
Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction
Thackeray, J. T., Derlin, T., Haghikia, A., Napp, L. C., Wang, Y., Ross, T. L., Schäfer, A., Tillmanns, J., Wester, H. J., Wollert, K. C., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.09.008 · Cited by 199
A highly selective and specific PET tracer for imaging of tau pathologies
Zhang, W., Arteaga, J., Cashion, D. K., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120712 · Cited by 195
Pandit-Taskar, N., O'Donoghue, J. A., Durack, J. C., Lyashchenko, S. K., Cheal, S. M., Beylergil, V., Lefkowitz, R. A., Carrasquillo, J. A., Martinez, D. F., Fung, A. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0552 · Cited by 195
Ikawa, M., Lohith, T. G., Shrestha, S., Telu, S., Zoghbi, S. S., Castellano, S., Taliani, S., Da Settimo, F., Fujita, M., Pike, V. W., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178996 · Cited by 195
Ulaner, G. A., Hyman, D. M., Ross, D. S., Corben, A., Chandarlapaty, S., Goldfarb, S., McArthur, H., Erinjeri, J. P., Solomon, S. B., Kolb, H., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.172031 · Cited by 191
Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
Vivash, L., & O’Brien, T. J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141713 · Cited by 190
Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies
Marquié, M., Normandin, M. D., Meltzer, A. C., Siao Tick Chong, M., Andrea, N. V., Antón‐Fernández, A., Klunk, W. E., Mathis, C. A., Ikonomovic, M. D., Debnath, M., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24844 · Cited by 190
Sander, K., Lashley, T., Gami, P., Gendron, T., Lythgoe, M. F., Rohrer, J. D., Schott, J. M., Revesz, T., Fox, N. C., & Årstad, E. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.003 · Cited by 187
Quiroz, Y. T., Sperling, R. A., Norton, D. J., Baena, A., Arboleda-Velasquez, J. F., Cosio, D., Schultz, A., Lapoint, M., Guzman-Velez, E., Miller, J. B., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4907 · Cited by 186
Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non–Small Cell Lung Cancer
Kandathil, A., Kay, F. U., Butt, Y. M., Wachsmann, J. W., & Subramaniam, R. M. (2018) · RadioGraphics · doi:10.1148/rg.2018180060 · Cited by 184
Ulaner, G. A., Lyashchenko, S. K., Riedl, C., Ruan, S., Zanzonico, P. B., Lake, D., Jhaveri, K., Zeglis, B., Lewis, J. S., & O’Donoghue, J. A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.202010 · Cited by 179
2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis
Tahara, N., Mukherjee, J., de Haas, H. J., Petrov, A. D., Tawakol, A., Haider, N., Tahara, A., Constantinescu, C. C., Zhou, J., Boersma, H. H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3437 · Cited by 177
Technetium‐99m radiochemistry for pharmaceutical applications
Papagiannopoulou, D. (2017) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3531 · Cited by 177
Schonhaut, D. R., McMillan, C. T., Spina, S., Dickerson, B. C., Siderowf, A., Devous, M. D., Tsai, R., Winer, J., Russell, D. S., Litvan, I., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25060 · Cited by 175
Quantification of Myocardial Blood Flow in Absolute Terms Using 82Rb PET Imaging
Nesterov, S. V., Deshayes, E., Sciagrà, R., Settimo, L., Declerck, J. M., Pan, X.-B., Yoshinaga, K., Katoh, C., Slomka, P. J., Germano, G., et al. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.08.003 · Cited by 174
11C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease
Kreisl, W. C., Lyoo, C. H., Liow, J.-S., Wei, M., Snow, J., Page, E., Jenko, K. J., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.011 · Cited by 174
Review on 99mTc radiopharmaceuticals with emphasis on new advancements
Duatti, A. (2021) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.05.005 · Cited by 174
TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward
Guilarte, T. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.003 · Cited by 173
In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
Villemagne, V. L., Furumoto, S., Fodero-Tavoletti, M. T., Mulligan, R. S., Hodges, J., Harada, R., Yates, P., Piguet, O., Pejoska, S., Doré, V., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2681-7 · Cited by 170
SPECT and PET imaging in Alzheimer’s disease
Valotassiou, V., Malamitsi, J., Papatriantafyllou, J., Dardiotis, E., Tsougos, I., Psimadas, D., Alexiou, S., Hadjigeorgiou, G., & Georgoulias, P. (2018) · Annals of Nuclear Medicine · doi:10.1007/s12149-018-1292-6 · Cited by 169
Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
Harada, R., Ishiki, A., Kai, H., Sato, N., Furukawa, K., Furumoto, S., Tago, T., Tomita, N., Watanuki, S., Hiraoka, K., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.197426 · Cited by 168
PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy
Wester, H.-J., & Schottelius, M. (2019) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2019.02.008 · Cited by 165
B cells in type 1 diabetes mellitus and diabetic kidney disease
Smith, M. J., Simmons, K. M., & Cambier, J. C. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.138 · Cited by 163
Sánchez-Vega, F., Hechtman, J. F., Castel, P., Ku, G. Y., Tuvy, Y., Won, H. H., Fong, C. J., Bouvier, N., Nanjangud, G. J., Soong, J., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0598 · Cited by 161
5‐HT radioligands for human brain imaging with PET and SPECT
Paterson, L. M., Kornum, B. R., Nutt, D., Pike, V. W., & Knudsen, G. M. (2011) · Medicinal Research Reviews · doi:10.1002/med.20245 · Cited by 159
Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques
Majmudar, M. D., Yoo, J., Keliher, E. J., Truelove, J. J., Iwamoto, Y., Sena, B. F., Dutta, P., Borodovsky, A., Fitzgerald, K. J., Carli, M. F. D., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300576 · Cited by 158
Laforest, R. A., Lapi, S. E., Oyama, R., Bose, R., Tabchy, A. B., Marquez-Nostra, B. V., Bartels, J. L., Wright, B. D., Frye, J., Frye, S. A., et al. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0951-z · Cited by 158
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Pandit-Taskar, N. D., O’Donoghue, J. A., Beylergil, V., Lyashchenko, S. K., Ruan, S., Solomon, S. B., Durack, J. C., Carrasquillo, J. A., Lefkowitz, R. A., Gönen, M., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2830-7 · Cited by 156
Keliher, E. J., Ye, Y., Wojtkiewicz, G. R., Aguirre, A. D., Tricot, B., Senders, M. L., Groenen, H., Fay, F., Pérez‐Medina, C., Calcagno, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14064 · Cited by 156
Current Perspectives on 89Zr-PET Imaging
Yoon, J., Park, B.-N., Ryu, E.-K., An, Y., & Lee, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124309 · Cited by 154
Rodriguez‐Vieitez, E., Ni, R., Gulyás, B. Z., Tóth, M., Häggkvist, J., Halldin, C., Voytenko, L. P., Marutle, A., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3047-0 · Cited by 149
Bensch, F., Brouwers, A. H., Hooge, M. N. L., de Jong, J. R., van der Vegt, B., Sleijfer, S., de Vries, E. G. E., & Schröder, C. P. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4099-8 · Cited by 149
Yasuno, F., Kosaka, J., Ota, M., Higuchi, M., Ito, H., Fujimura, Y., Nozaki, S., Takahashi, S., Mizukami, K., Asada, T., et al. (2012) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.08.013 · Cited by 148
Pandit-Taskar, N. D., O’Donoghue, J. A., Ruan, S., Lyashchenko, S. K., Carrasquillo, J. A., Heller, G., Martinez, D. F., Cheal, S. M., Lewis, J. S., Fleisher, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.176206 · Cited by 146
SPECT/CT: an update on technological developments and clinical applications
Ljungberg, M. H., & Pretorius, P. H. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160402 · Cited by 144
Vermeiren, C., Motte, P., Viot, D., Mairet‐Coello, G., Courade, J., Citron, M., Mercier, J., Hannestad, J., & Gillard, M. (2018) · Movement Disorders · doi:10.1002/mds.27271 · Cited by 143
PET Imaging of Bacterial Infections with Fluorine‐18‐Labeled Maltohexaose
Ning, X., Seo, W., Lee, S., Takemiya, K., Rafi, M., Feng, X., Weiss, D., Wang, X., Williams, L., Camp, V. M., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408533 · Cited by 143
The clinical use of PET with (11)C-acetate.
Grassi, I., Nanni, C., Allegri, V., Morigi, J. J., Montini, G. C., Castellucci, P., & Fanti, S. (2012) · Europe PMC (PubMed Central) · Cited by 143
Nodwell, M. B., Yang, H., Čolović, M., Yuan, Z., Merkens, H., Martin, R. E., Bénard, F., Schaffer, P. C., & Britton, R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b11533 · Cited by 143
Petrou, M., Frey, K. A., Kilbourn, M. R., Scott, P. J. H., Raffel, D. M., Bohnen, N. I., Müller, M. L. T. M., Albin, R. L., & Koeppe, R. A. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.124792 · Cited by 142
An Overview of PET Radiochemistry, Part 2: Radiometals
Brandt, M., Cardinale, J., Aulsebrook, M. L., Gasser, G., & Mindt, T. L. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.190801 · Cited by 140
Basics and principles of radiopharmaceuticals for PET/CT
Wadsak, W., & Mitterhauser, M. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.12.022 · Cited by 139
Ching, A. S. C., Kühnast, B., Damont, A., Roeda, D., Tavitian, B., & Dollé, F. (2011) · Insights into Imaging · doi:10.1007/s13244-011-0128-x · Cited by 139
Bacterial infection imaging with [ 18 F]fluoropropyl-trimethoprim
Sellmyer, M. A., Lee, I., Hou, C., Weng, C.-C., Li, S., Lieberman, B. P., Zeng, C., Mankoff, D. A., & Mach, R. H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703109114 · Cited by 139
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
van Oordt, C. W. M. D. H., Gootjes, E. C., Huisman, M. C., Vugts, D. J., Roth, C., Luik, A. M., Mulder, E. R., Schuit, R. C., Boellaard, R., Hoekstra, O. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4672 · Cited by 137
Ulaner, G. A., Hyman, D. M., Lyashchenko, S. K., Lewis, J. S., & Carrasquillo, J. A. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001820 · Cited by 137
Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
Lenzo, N. P., Meyrick, D. P., & Turner, J. H. (2018) · Diagnostics · doi:10.3390/diagnostics8010016 · Cited by 136
Heo, G. S., Kopecky, B. J., Sultan, D. H., Ou, M., Feng, G., Bajpai, G., Zhang, X., Luehmann, H. P., Detering, L., Su, Y., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314030 · Cited by 135
McCluskey, S. P., Plisson, C., Rabiner, E. A., & Howes, O. D. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04488-0 · Cited by 135
Imaging atherosclerosis with positron emission tomography
Joseph, P., & Tawakol, A. A. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw147 · Cited by 134
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Chiotis, K., Saint‐Aubert, L., Savitcheva, I., Jelić, V., Andersen, P., Jonasson, M., Eriksson, J., Lubberink, M., Almkvist, O., Wall, A. E., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3363-z · Cited by 133
Bohnen, N. I., Grothe, M. J., Ray, N. J., Müller, M. L. T. M., & Teipel, S. J. (2018) · Current Geriatrics Reports · doi:10.1007/s13670-018-0234-4 · Cited by 133
Li, X., Samnick, S., Lapa, C., Israel, I., Buck, A. K., Kreissl, M. C., & Bauer, W. R. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-52 · Cited by 128
O’Donoghue, J. A., Lewis, J. S., Pandit-Taskar, N. D., Fleming, S. E., Schöder, H. M., Larson, S. M., Beylergil, V., Ruan, S., Lyashchenko, S. K., ZANZONICO, P. B., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.194555 · Cited by 127
18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke
Boutin, H., Murray, K. N., Pradillo, J. M., Maroy, R., Smigova, A., Gerhard, A., Jones, P. A., & Trigg, W. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2939-8 · Cited by 126
Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment
Maëcke, H. R., & Reubi, J. C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.084236 · Cited by 125
Weiberg, D., Thackeray, J. T., Daum, G., Sohns, J. M. S., Kropf, S., Wester, H., Roß, T. L., Bengel, F. M., & Derlin, T. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.196485 · Cited by 125
Pedersen, S., Sandholt, B. V., Keller, S. H., Hansen, A. E., Clemmensen, A., Sillesen, H. H., Højgaard, L., Ripa, R. S., & Kjær, A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.305067 · Cited by 123
Heukelom, J., Hamming‐Vrieze, O., Bartelink, H. G. M. M., Hoebers, F. J. P., Giralt, J., Herlestam, T., Verheij, M., van den Brekel, M. W. M., Vogel, W. V., Slevin, N., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-84 · Cited by 121
Gaykema, S. B. M., Schröder, C. P., Vitfell-Rasmussen, J., Chua, S. C., Munnink, T. H. O., Brouwers, A. H., Bongaerts, A. H. H., Akimov, M., Fernandez‐Ibarra, C., Hooge, M. N. L., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0491 · Cited by 121
Prior, J. O., Allenbach, G., Valenta, I., Kosinski, M., Burger, C., Verdun, F. R., Delaloye, A. B., & Kaufmann, P. A. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2082-3 · Cited by 120
Fotis, L., Agrogiannis, G., Vlachos, I. S., Pantopoulou, A., Margoni, A., Kostaki, M., Verikokos, C., Tzivras, D. M., Mikhailidis, D. P., & Perrea, D. N. (2012) · PubMed · Cited by 120
11C-Acetate PET/CT in Localized Prostate Cancer: A Study with MRI and Histopathologic Correlation
Mena, E., Türkbey, B., Mani, H., Adler, S., Valera, V., Bernardo, M., Shah, V. P., Pohida, T. J., McKinney, Y. L., Kwarteng, G., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.096032 · Cited by 119
Koole, M., van Aalst, J., Devrome, M., Mertens, N., Serdons, K., Lacroix, B., Mercier, J., Sciberras, D., Maguire, P., & Van Laere, K. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4119-8 · Cited by 118
99m Tc-3PRGD2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study
Zhu, Z., Miao, W., Li, Q., Dai, H., Ma, Q., Wang, F., Yang, A., Jia, B., Jing, X., Liu, S., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098988 · Cited by 118
Guo, Q., Colasanti, A., Owen, D. R., Ónega, M., Kamalakaran, A., Bennacef, I., Matthews, P., Rabiner, E., Turkheimer, F., & Gunn, R. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.121020 · Cited by 117
Insights into neuroepigenetics through human histone deacetylase PET imaging
Wey, H., Gilbert, T. M., Zürcher, N. R., She, A., Bhanot, A., Taillon, B. D., Schroeder, F. A., Wang, C., Haggarty, S. J., & Hooker, J. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7551 · Cited by 117
Verhoeff, S. R., van Es, S. C., Boon, E., Helden, E. J. V., Angus, L., Elias, S. G., Oosting, S. F., Aarntzen, E. H. J. G., Brouwers, A. H., Kwee, T. C., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04358-9 · Cited by 116
Oosting, S. F., Brouwers, A. H., van Es, S. C., Nagengast, W. B., Munnink, T. H. O., Hooge, M. N. L., Hollema, H., de Jong, J. R., de Jong, I. J., de Haas, S., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.144840 · Cited by 115
Liu, B., Le, K. X., Park, M.-A., Wang, S., Belanger, A. P., Dubey, S., Frost, J. L., Holton, P., Reiser, V., Jones, P. A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0996-15.2015 · Cited by 114
Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis
Senders, M. L., Hernot, S., Carlucci, G., van de Voort, J. C., Fay, F., Calcagno, C., Tang, J., Alaarg, A., Zhao, Y., Ishino, S., et al. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.07.027 · Cited by 113
Hyafil, F., Pelisek, J., Laitinen, I., Schottelius, M., Mohring, M., Döring, Y., van der Vorst, E. P. C., Kallmayer, M. A., Steiger, K., Poschenrieder, A., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.179663 · Cited by 112
A Systematic Approach for Developing Bacteria-Specific Imaging Tracers
Ordoñez, A. A., Weinstein, E. A., Bambarger, L. E., Saini, V., Chang, Y. S., DeMarco, V. P., Klunk, M. H., Urbanowski, M. E., Moulton, K. L., Murawski, A. M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.181792 · Cited by 111
Wang, C., Schroeder, F. A., Wey, H., Borra, R., Wagner, F. F., Reis, S. A., Kim, S. W., Holson, E. B., Haggarty, S. J., & Hooker, J. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500872p · Cited by 110
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study
Einspieler, I., Thürmel, K., Pyka, T., Eiber, M., Wolfram, S., Moog, P., Reeps, C., & Essler, M. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3007-8 · Cited by 110
Radioiodine: The Classic Theranostic Agent
Silberstein, E. B. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.12.002 · Cited by 110
Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
Delva, A., Weehaeghe, D. V., Koole, M. J. B., Laere, K. V., & Vandenberghe, W. (2020) · Movement Disorders · doi:10.1002/mds.28216 · Cited by 110
Insight into the Development of PET Radiopharmaceuticals for Oncology
Lau, J., Rousseau, É., Kwon, D., Lin, K., Bénard, F., & Chen, X. S. (2020) · Cancers · doi:10.3390/cancers12051312 · Cited by 109
Cholinergic imaging in dementia spectrum disorders
Roy, R., Niccolini, F., Pagano, G., & Politis, M. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3349-x · Cited by 108
Wekerle, H. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1281914 · Cited by 108
Wong, D. F., Comley, R. A., Kuwabara, H., Rosenberg, P. B., Resnick, S. M., Ostrowitzki, S., Vozzi, C., Boess, F., Oh, E. S., Lyketsos, C. G., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.209916 · Cited by 108
Human Positron Emission Tomography Neuroimaging
Hooker, J. M., & Carson, R. E. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121056 · Cited by 105
Minoshima, S., Mosci, K., Cross, D. J., & Thientunyakit, T. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2021.01.002 · Cited by 105
Fujita, M., Kobayashi, M., Ikawa, M., Gunn, R. N., Rabiner, E. A., Owen, D. R., Zoghbi, S. S., Haskali, M. B., Telu, S., Pike, V. W., et al. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0334-8 · Cited by 104
PET Imaging of PARP Expression Using 18 F-Olaparib
Wilson, T. C., Xavier, M.-A. E., Knight, J. C., Verhoog, S., Torres, J. B., Mosley, M. J., Hopkins, S. L., Wallington, S., Allen, P. D., Kersemans, V., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.213223 · Cited by 104
Gowrishankar, G., Hardy, J. W., Wardak, M., Namavari, M., Reeves, R. E., Neofytou, E. A., Srinivasan, A., Wu, J. C., Contag, C. H., & Gambhir, S. S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191452 · Cited by 103
In vivo evidence of lower synaptic vesicle density in schizophrenia
Radhakrishnan, R., Skosnik, P. D., Ranganathan, M., Naganawa, M., Toyonaga, T., Finnema, S., Hillmer, A. T., Esterlis, I., Huang, Y., Nabulsi, N., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01184-0 · Cited by 100
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with18F-PBR111 PET
Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.135129 · Cited by 100
Lamberts, L. E., van Oordt, C. W. M. D. H., ter Weele, E. J., Bensch, F., Smeenk, M. M., Voortman, J., Hoekstra, O. S., Williams, S. P., Fine, B. M., Maslyar, D. J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1272 · Cited by 100
Carbon Dioxide Chemistry, Capture and Oil Recovery
Karamé, I., Shaya, J., & Srour, H. M. (2018) · InTech eBooks · doi:10.5772/intechopen.68466 · Cited by 99
Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.
Castaldi, P., Leccisotti, L., Bussu, F., Miccichè, F., & Rufini, V. (2013) · PubMed Central · Cited by 98
Investigation of 6-[18F]-Fluoromaltose as a Novel PET Tracer for Imaging Bacterial Infection
Gowrishankar, G., Namavari, M., Jouannot, E., Höhne, A., Reeves, R. E., Hardy, J. W., & Gambhir, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107951 · Cited by 98
11CO2 fixation: a renaissance in PET radiochemistry
Rotstein, B. H., Liang, S. H., Holland, J. P., Collier, T. L., Hooker, J. M., Wilson, A. A., & Vasdev, N. (2013) · Chemical Communications · doi:10.1039/c3cc42236d · Cited by 98
Kong, B. Y., Menzies, A. M., Saunders, C. A. B., Liniker, E., Ramanujam, S., Guminski, A. D., Kefford, R. F., Long, G. V., & Carlino, M. S. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12503 · Cited by 97
Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation
Choi, J. Y., Cho, H., Ahn, S. J., Lee, J., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195248 · Cited by 97
Wolk, D. A., Sadowsky, C., Safirstein, B., Rinne, J. O., Duara, R., Perry, R. J., Agronin, M., Gamez, J., Shi, J., Ivanoiu, A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0894 · Cited by 97
Dedeurwaerdere, S., Callaghan, P. D., Pham, T. Q., Rahardjo, G., Amhaoul, H., Berghofer, P., Quinlivan, M., Mattner, F., Loc’h, C., Katsifis, A. G., et al. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-60 · Cited by 96
68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer
Zhang, J., Mao, F., Niu, G., Peng, L., Lang, L., Li, F., Ying, H., Wu, H., Pan, B., Zhu, Z., et al. (2018) · Theranostics · doi:10.7150/thno.22601 · Cited by 95
Honer, M., Gobbi, L. B., Knust, H., Kuwabara, H., Muri, D., Koerner, M., Valentine, H., Dannals, R. F., Wong, D. F., & Borroni, E. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.196741 · Cited by 93
Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
Lau, J., Lin, K., & Bénard, F. (2017) · Theranostics · doi:10.7150/thno.21848 · Cited by 92
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading
Katsanos, A. H., Alexiou, G. Α., FOTOPOULOS, A. D., Jabbour, P. M., Kyritsis, A. P., & Sioka, C. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002654 · Cited by 92
Varrone, A., Mattsson, P., Forsberg, A., Takano, A., Nag, S., Gulyás, B. Z., Borg, J., Boellaard, R., Al‐Tawil, N. G., Eriksdotter, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2359-1 · Cited by 90
Molecular Drug Imaging: 89Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma
Jansen, M. H. A., van Zanten, S. E. M. V., van Vuurden, D. G., Huisman, M. C., Vugts, D. J., Hoekstra, O. S., van Dongen, G. A. M. S., & Kaspers, G. J. L. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180216 · Cited by 90
PET Imaging of Lung Inflammation with [18F]FEDAC, a Radioligand for Translocator Protein (18 kDa)
Hatori, A., Yui, J., Yamasaki, T., Xie, L., Kumata, K., Fujinaga, M., Yoshida, Y., Ogawa, M., Nengaki, N., Kawamura, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045065 · Cited by 89
Lu, G., Maresca, K. P., Hillier, S., Zimmerman, C. N., Eckelman, W. C., Joyal, J. L., & Babich, J. W. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.014 · Cited by 89
PET/CT Imaging of Chemokine Receptor CCR5 in Vascular Injury Model Using Targeted Nanoparticle
Luehmann, H. P., Pressly, E. D., Detering, L., Wang, C., Pierce, R. A., Woodard, P. K., Gropler, R. J., Hawker, C. J., & Liu, Y. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.132001 · Cited by 89
Malmberg, C. A. E., Ripa, R. S., Johnbeck, C. B., Knigge, U., Langer, S. W., Mortensen, J., Oturai, P., Loft, A., Hag, A. M. F., & Kjær, A. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161216 · Cited by 89
Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis
Ye, Y., Calcagno, C., Binderup, T., Courties, G., Keliher, E. J., Wojtkiewicz, G. R., Iwamoto, Y., Tang, J., Pérez‐Medina, C., Mani, V., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.307024 · Cited by 87
Sridharan, S., Lepelletier, F.-X., Trigg, W., Banister, S. D., Reekie, T. A., Kassiou, M., Gerhard, A., Hinz, R., & Boutin, H. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0984-3 · Cited by 87
Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
Wooten, D., Guehl, N. J., Verwer, E. E., Shoup, T. M., Yokell, D. L., Zubcevik, N., Vasdev, N., ZAFONTE, R. D., Johnson, K. A., Fakhri, G. E., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170910 · Cited by 87
Carney, B. D., Kossatz, S., & Reiner, T. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189936 · Cited by 87
Cimadamore, A., Cheng, M., Santoni, M., Antonio Lopez-beltran, B., Battelli, N., Massari, F., Galosi, A. B., Scarpelli, M., & Montironi, R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00653 · Cited by 87
Li, X., Bauer, W. R., Kreissl, M. C., Weirather, J., Bauer, E., Israel, I., Richter, D., Riehl, G., Buck, A. K., & Samnick, S. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.018 · Cited by 85
Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Site in Human Brain
Tyacke, R. J., Myers, J., Venkataraman, A. V., Mick, I., Turton, S., Passchier, J., Husbands, S. M., Rabiner, E. A., Gunn, R. N., Murphy, P. S., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.208009 · Cited by 85
Exendin‐4 analogs in insulinoma theranostics
Jansen, T. J. P., van Lith, S. A. M., Boss, M., Brom, M., Joosten, L., Béhé, M. P., Buitinga, M., & Gotthardt, M. (2019) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3750 · Cited by 85
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095
Afshar‐Oromieh, A., Haberkorn, U., Zechmann, C. M., Armor, T., Mier, W., Spohn, F., Debus, N., Holland‐Letz, T., Babich, J. W., & Kratochwil, C. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3665-9 · Cited by 84
11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
Datta, G., Colasanti, A., Kalk, N. J., Owen, D. R., Scott, G., Rabiner, E. A., Gunn, R. N., Lingford-Hughes, A. R., Malik, O., Ciccarelli, O., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.187161 · Cited by 84
Mirzaei, N., Tang, S. P., Ashworth, S., Coello, C., Plisson, C., Passchier, J., Selvaraj, V., Tyacke, R. J., Nutt, D. J., & Sastre, M. (2016) · Glia · doi:10.1002/glia.22978 · Cited by 82
Ishiki, A., Okamura, N., Furukawa, K., Furumoto, S., Harada, R., Tomita, N., Hiraoka, K., Watanuki, S., Ishikawa, Y., Tago, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140311 · Cited by 82
B cells in chronic graft-versus-host disease
McManigle, W. C., Youssef, A., & Sarantopoulos, S. (2019) · Human Immunology · doi:10.1016/j.humimm.2019.03.003 · Cited by 82
Derlin, T., Sedding, D., Dutzmann, J., Haghikia, A., König, T., Napp, L. C., Schütze, C., Owsianski-Hille, N., Wester, H., Kropf, S., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4076-2 · Cited by 81
Wang, R., Shen, G., Huang, M., & Tian, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684629 · Cited by 81
Osborne, J. R., Green, D. A., Spratt, D. E., Lyashchenko, S. K., Fareedy, S. B., Robinson, B. D., Beattie, B. J., Jain, M., Lewis, J. S., Christos, P. J., et al. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.10.041 · Cited by 80
Unterrainer, M., Mahler, C. F., Vomacka, L., Lindner, S., Havla, J. B., Brendel, M., Böning, G., Ertl-Wagner, B. B., Kümpfel, T., Milenkovic, V. M., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3974-7 · Cited by 80
Test-retest reproducibility for the tau PET imaging agent flortaucipir F 18.
Devous, M. D., Joshi, A. D., Navitsky, M., Southekal, S., Pontecorvo, M. J., Shen, H., Lu, M., Shankle, W. R., Seibyl, J. P., Marek, K., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.200691 · Cited by 79
Journey in Evolution of Nuclear Cardiology
Dilsizian, V., & Taillefer, R. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.10.006 · Cited by 79
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
Pandit-Taskar, N. D., O’Donoghue, J. A., Divgi, C. R., Wills, E. A., Schwartz, L. H., Gönen, M., Smith-Jones, P. M., Bander, N. H., Scher, H. I., Larson, S. M., et al. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0104-4 · Cited by 79
Cited by
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Kamatham, P. T., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 371
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“…delivery Radiopharmaceutical labeling for tracking gene delivery ‑ Nucleic acid delivery for gene therapy ‑ Targeted gene editing and modulation [73] Personalized medicine Radiotracer‑guided customization of drug delivery ‑ Tailored drug delivery based on patient‑specific Customized treatment…”
BackgroundStrobel, J., Müller, H.-P., Ludolph, A. C., Beer, A. J., Sollmann, N., & Kassubek, J. (2023) · Cells · doi:10.3390/cells12242776 · Cited by 10
Metadata
- Authors
- Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-04-30
- Volume
- 23
- Issue
- 9
- Pages
- 5023
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4225247599
- Cited by
- 337
- References
- 413
- FWCI
- 34.37
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.